Maya Ridinger

Director of Research & Development @Cardiff Oncology

Direct the preclinical and translational research for the development of the PLK1 inhibitor, Onvansertib Supervise and guide the preclinical research as it pertains to a greater understanding of drug mechanism of action, identifying new combinations and assessing efficacy within new indications Work with cross-functional teams for the development, implementation, and analyses of pharmacodynamic and patient response biomarkers for clinical studies Initiate, coordinate and…